<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the prevalence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL) in children with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The study was carried out in 10 consecutive patients during the first days of neurological symptoms </plain></SENT>
<SENT sid="2" pm="."><plain>aPL detected as <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> or anticardiolipin antibodies (aCL) and natural <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> proteins C, S, and antithrombin III were determined in <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Seven patients had <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarctions</z:e> associated with aCL; 4 of these patients had high serum aCL concentrations in 2 different determinations (<z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>) </plain></SENT>
<SENT sid="4" pm="."><plain>Two patients had temporary <z:hpo ids='HP_0005543'>protein C deficiency</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>In one patient with negative aCL, protein C, S, and antithrombin III determinations were not carried out </plain></SENT>
<SENT sid="6" pm="."><plain>No patient had evidence of <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disease</z:e> or family history of <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable state</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>After followup of 15.7 months, no patient had recurrent infarction while taking aspirin </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Our study demonstrates high prevalence of aCL in children who suffer <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> and our results suggest aspirin may be effective therapy to prevent recurrences </plain></SENT>
</text></document>